Business TriSalus Life Sciences Receives Mixed Analyst Ratings Ahead of Earnings Shares of TriSalus Life Sciences, Inc. (NASDAQ: TLSI) recently received a consensus rating of “Hold” from five brokerages monitoring the stock, according to a... Editorial1 day ago